Awaiting results for a Phase 3 study for this drug to combat cytokine storm in severe COVID-19 cases. The stock is nuts cytodyn.com/newsroom/press…

Fantastic m2m results out! P=.0223 When you consider that m2m is the hardest group to show any clinical improvement in it makes these results that much more impressive! cytodyn.com/newsroom/press…

Want a treatment for #Covid? $CytoDynb has one. Trial data released this morning, endpoints met. #loranlimab has to be approved. This blows $GILD's Remdisivir AWAY! cytodyn.com/newsroom/press…

I am cynical about the government's politicized search for a #Covid treatment. Like children in a scary movie, they throw billions at politically connected companies. $CYDY's Leronlimab is the dark horse to win the Covid sweepstakes. Dave Portnoy youtube.com/watch?v=qu08pT…

Michael Savage Sad big-Pharma appears to be influencing the care of our President by admin drugs that have limited impacts on COVID. The science, MOA, Mild/Mod stat-sig Ph2 results and 6+ yrs safe in HIV trials of #leronlimab are being overlooked. It decreases virus, C-storm, restores immune.